$67.00
You’ll be briefly redirected to Link Money, our secure ACH payment partner, to connect your bank and complete payment.– Your bank login is never visible to or stored by us – Encrypted, bank-level security – A standard, trusted payment process
In controlled laboratory environments, PT 141 is studied for its interaction with the melanocortin receptor and downstream signaling pathways within central nervous system models. Research indexed on Google Scholar evaluates its influence on neuroendocrine pathways associated with sexual desire, libido, arousal, and behavioral motivation signaling.
Scientific publications reference experimental investigations involving hypoactive sexual desire disorder, female sexual dysfunction, and broader models of sexual dysfunction, including those involving low libido, low sexual desire, and altered sexual motivation pathways. Academic research has also explored mechanistic models discussing erectile dysfunction, erectile function, penile erection, and comparisons to PDE5 inhibitors in theoretical frameworks.
Additional laboratory studies examine receptor-mediated pathways potentially influencing systemic parameters such as blood pressure, blood flow, and energy regulation. These references are limited strictly to research literature and do not represent approved human application.
While published clinical trial literature discusses use in specific populations such as premenopausal women, this product is supplied strictly for laboratory research and is not intended for administration by injection, nasal spray, or any other delivery method. It is not intended to establish a new standard of care, not approved for treatment, and not a substitute for evaluation by a healthcare provider.
All discussions of sexual performance, sexual satisfaction, sexual activity, sexual health, or sexual wellness remain confined to academic and experimental research contexts. References to weight loss, metabolic pathways, or other physiological endpoints reflect exploratory research models only.
Not an approved PT 141 therapy, not peptide therapy, and not a medical treatment
PT 141 (Bremelanotide) is a synthetic melanocortin peptide analog studied for its activity at the melanocortin receptor, particularly MC3R and MC4R, in laboratory research settings.
No. This product is not a PT 141 nasal spray, not intranasal PT 141, and not formulated for PT 141 injection. It is supplied strictly as a lyophilized powder for research use only.
This product is not approved for treatment of erectile dysfunction, hypoactive sexual desire disorder, or any form of sexual dysfunction. References to these conditions appear in scientific literature and clinical research discussions only.
No. This product is not approved for PT 141 peptide therapy, not PT 141 therapy, and not peptide therapy. It is sold strictly for laboratory research purposes.
